Cargando…

The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study

Background and Aim: Applying fractional flow reserve (FFR) recently helped to assess borderline coronary defects and also facilitates assessment of these lesions. The present study aimed to assess cost-effectiveness of FFR in detection of these borderline lesions. Methods: This cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Morteza, Safi, Mohammad, Ali Mehrabi, Saeed, Alipour Parsa, Isa, Khaheshi, Mohammadreza, Naderian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502121/
https://www.ncbi.nlm.nih.gov/pubmed/30333462
http://dx.doi.org/10.23750/abm.v89i3.5605
_version_ 1783416211233570816
author Morteza, Safi
Mohammad, Ali Mehrabi
Saeed, Alipour Parsa
Isa, Khaheshi
Mohammadreza, Naderian
author_facet Morteza, Safi
Mohammad, Ali Mehrabi
Saeed, Alipour Parsa
Isa, Khaheshi
Mohammadreza, Naderian
author_sort Morteza, Safi
collection PubMed
description Background and Aim: Applying fractional flow reserve (FFR) recently helped to assess borderline coronary defects and also facilitates assessment of these lesions. The present study aimed to assess cost-effectiveness of FFR in detection of these borderline lesions. Methods: This cross-sectional study was conducted on140 consecutive patients with 219 diseased arteries who underwent coronary angiography and suffered intermediate coronary lesions. Results: Of 18 patients who candidate for CABG before FFR, only one patient underwent CABG after determining FFR (P-value<0.05), while 15 patients were scheduled for PCI and 2 patients for medical treatment. Of 122 patients who candidate for PCI, 59 were programmed to underwent PCI after FFR determination (P-value<0.05), while the strategy in 63 patients (47 with one-vessel disease, 15 with two vessel diseases, and 1 with three vessel diseases) was modified to medical treatment. Considering strategy modifying from PCI to medical treatment, 101 stents were saved (P-value<0.05). Also, in change of strategy from CABG to PCI, spending has decreased as much as 77.3% (P-value<0.05). Furthermore, the change of treatment approach from PCI on much number of coronary vessels to PCI on less number of coronary lesions led to saving of 52.2% of costs (P-value<0.05). Conclusions:In patients with an intermediate coronary lesion, measuring FFR to guide the decision to determine treatment strategy may lead to significant cost savings. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-6502121
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-65021212019-05-08 The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study Morteza, Safi Mohammad, Ali Mehrabi Saeed, Alipour Parsa Isa, Khaheshi Mohammadreza, Naderian Acta Biomed Original Article Background and Aim: Applying fractional flow reserve (FFR) recently helped to assess borderline coronary defects and also facilitates assessment of these lesions. The present study aimed to assess cost-effectiveness of FFR in detection of these borderline lesions. Methods: This cross-sectional study was conducted on140 consecutive patients with 219 diseased arteries who underwent coronary angiography and suffered intermediate coronary lesions. Results: Of 18 patients who candidate for CABG before FFR, only one patient underwent CABG after determining FFR (P-value<0.05), while 15 patients were scheduled for PCI and 2 patients for medical treatment. Of 122 patients who candidate for PCI, 59 were programmed to underwent PCI after FFR determination (P-value<0.05), while the strategy in 63 patients (47 with one-vessel disease, 15 with two vessel diseases, and 1 with three vessel diseases) was modified to medical treatment. Considering strategy modifying from PCI to medical treatment, 101 stents were saved (P-value<0.05). Also, in change of strategy from CABG to PCI, spending has decreased as much as 77.3% (P-value<0.05). Furthermore, the change of treatment approach from PCI on much number of coronary vessels to PCI on less number of coronary lesions led to saving of 52.2% of costs (P-value<0.05). Conclusions:In patients with an intermediate coronary lesion, measuring FFR to guide the decision to determine treatment strategy may lead to significant cost savings. (www.actabiomedica.it) Mattioli 1885 2018 /pmc/articles/PMC6502121/ /pubmed/30333462 http://dx.doi.org/10.23750/abm.v89i3.5605 Text en Copyright: © 2018 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Morteza, Safi
Mohammad, Ali Mehrabi
Saeed, Alipour Parsa
Isa, Khaheshi
Mohammadreza, Naderian
The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
title The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
title_full The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
title_fullStr The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
title_full_unstemmed The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
title_short The role of FFR in clinical decision making in patients with moderate coronary lesions: a pilot study
title_sort role of ffr in clinical decision making in patients with moderate coronary lesions: a pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502121/
https://www.ncbi.nlm.nih.gov/pubmed/30333462
http://dx.doi.org/10.23750/abm.v89i3.5605
work_keys_str_mv AT mortezasafi theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT mohammadalimehrabi theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT saeedalipourparsa theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT isakhaheshi theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT mohammadrezanaderian theroleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT mortezasafi roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT mohammadalimehrabi roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT saeedalipourparsa roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT isakhaheshi roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy
AT mohammadrezanaderian roleofffrinclinicaldecisionmakinginpatientswithmoderatecoronarylesionsapilotstudy